Investing.com - Financial Markets Worldwide
🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

Injective (INJ) Price Up 4+% While Rest of the Market Bleeds

Published 18/08/2023, 12:03
Injective (INJ) Price Up 4+% While Rest of the Market Bleeds
ENJ/USD
-

  • An analyst commended INJ for its consistent performance over the past year.

  • According to CoinMarketCap, INJ was one of the few cryptocurrencies that saw its price rise over the past day of trading.

  • From a technical perspective, INJ’s 9-day EMA line was attempting to cross above the 20-day EMA line at press time.

Injective (INJ) was commended for its consistent performance throughout the past year by a cryptocurrency analyst on Twitter this morning. According to the analyst, INJ has shown considerable strength, and although it’s not running “hot” 24/7, its dips are usually shallow and it seems to outperform most altcoins the majority of the time.

Latest comments

Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2024 - Fusion Media Limited. All Rights Reserved.